Improved coronary magnetic resonance angiography using gadobenate dimeglumine in pediatric congenital heart disease
Tài liệu tham khảo
Tangcharoen, 2011, Detection of coronary artery anomalies in infants and young children with congenital heart disease by using MR imaging, Radiology, 259, 240, 10.1148/radiol.10100828
Valsangiacomo Buechel, 2015, Indications for cardiovascular magnetic resonance in children with congenital and acquired heart disease: an expert consensus paper of the imaging working group of the AEPC and the cardiovascular magnetic resonance section of the EACVI, Eur Heart J Cardiovasc Imaging, 16, 281, 10.1093/ehjci/jeu129
Bunce, 2003, Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography, Radiology, 227, 201, 10.1148/radiol.2271020316
Wang, 1996, Navigator-echo-based real-time respiratory gating and triggering for reduction of respiration effects in three-dimensional coronary MR angiography, Radiology, 198, 55, 10.1148/radiology.198.1.8539406
Henningsson, 2013, Prospective respiratory motion correction for coronary MR angiography using a 2D image navigator, Magn Reson Med, 69, 486, 10.1002/mrm.24280
Piccini, 2014, Respiratory self-navigated postcontrast whole-heart coronary MR angiography: initial experience in patients, Radiology, 270, 378, 10.1148/radiol.13132045
HH, 2013, Free-breathing multiphase whole-heart coronary MR angiography using image-based navigators and three-dimensional cones imaging, Magn Reson Med, 69, 1083, 10.1002/mrm.24346
Taylor, 2005, MR coronary angiography and late-enhancement myocardial MR in children who underwent arterial switch surgery for transposition of great arteries, Radiology, 234, 542, 10.1148/radiol.2342032059
Bi, 2007, Whole-heart coronary magnetic resonance angiography at 3Tesla in 5 minutes with slow infusion of Gd-BOPTA, a high-relaxivity clinical contrast agent, Magn Reson Med, 58, 1, 10.1002/mrm.21224
Klein, 2008, Combined magnetic resonance coronary artery imaging, myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease, J Cardiovasc Magn Reson, 10, 45, 10.1186/1532-429X-10-45
Hu, 2011, Contrast-enhanced whole-heart coronary MRI with bolus infusion of gadobenate dimeglumine at 1.5T, Magn Reson Med, 65, 392, 10.1002/mrm.22706
Makowski, 2011, Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent, Radiology, 260, 680, 10.1148/radiol.11102327
Stuber, 1999, Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography, J Magn Reson Imaging, 10, 790, 10.1002/(SICI)1522-2586(199911)10:5<790::AID-JMRI25>3.0.CO;2-I
Saeed, 2000, Blood pool MR contrast agents for cardiovascular imaging, J Magn Reson Imaging, 12, 890, 10.1002/1522-2586(200012)12:6<890::AID-JMRI12>3.0.CO;2-K
Yun, 2014, Coronary artery angiography and myocardial viability imaging: a 3.0-T contrast-enhanced magnetic resonance coronary artery angiography with Gd-BOPTA, Int J Cardiovasc Imaging, 30, 99, 10.1007/s10554-013-0297-4
Sakuma, 2005, Assessment of coronary arteries with total study time of less than 30minutes by using whole-heart coronary MR angiography, Radiology, 237, 316, 10.1148/radiol.2371040830
Cavagna, 1997, Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging, Invest Radiol, 32, 780, 10.1097/00004424-199712000-00009
Henningsson, 2018, Coronary MR angiography using image-based respiratory motion compensation with inline correction and fixed gating efficiency, Magn Reson Med, 79, 416, 10.1002/mrm.26678
Yu, 2011, Practical signal-to-noise ratio quantification for sensitivity encoding: application to coronary MR angiography, J Magn Reson Imaging, 33, 1330, 10.1002/jmri.22571
Etienne, 2002, “Soap-Bubble” visualization and quantitative analysis of 3D coronary magnetic resonance angiograms, Magn Reson Med, 48, 658, 10.1002/mrm.10253
Botnar, 1999, Improved coronary artery definition with T2-weighted, free-breathing, three-dimensional coronary MRA, Circulation, 99, 3139, 10.1161/01.CIR.99.24.3139
Leipsic, 2014, SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee, J Cardiovasc Comput Tomogr, 8, 342, 10.1016/j.jcct.2014.07.003
Uribe, 2011, Congenital heart disease in children: coronary MR angiography during systole and diastole with dual cardiac phase whole-heart imaging, Radiology, 260, 232, 10.1148/radiol.11101659
Bland, 1986, Statistical methods for assessing agreement between two methods of clinical measurement, Lancet, 1, 307, 10.1016/S0140-6736(86)90837-8
Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310
Henningsson, 2012, Whole-heart coronary MR angiography with 2D self-navigated image reconstruction, Magn Reson Med, 67, 437, 10.1002/mrm.23027
Shen, 2015, T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7T, Invest Radiol, 50, 330, 10.1097/RLI.0000000000000132
Hazirolan, 2005, Reproducibility of black-blood coronary vessel wall MR imaging, J Cardiovasc Magn Reson, 7, 409, 10.1081/JCMR-200053464
Ni, 2012, 31
Stillman, 1996, Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients, J Comput Assist Tomogr, 20, 51, 10.1097/00004728-199601000-00011
Schneider, 2007, Gadobenate dimeglumine-enhanced MR angiography: diagnostic performance of four doses for detection and grading of carotid, renal, and aorto-iliac stenoses compared to digital subtraction angiography, J Magn Reson Imaging, 26, 1020, 10.1002/jmri.21127
Yang, 2009, Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0-T: a comparative study with X-ray angiography in a single center, J Am Coll Cardiol, 54, 69, 10.1016/j.jacc.2009.03.016